Published in Acta Virol on September 01, 1990
Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc Natl Acad Sci U S A (1992) 6.85
A novel nuclear export activity in HIV-1 matrix protein required for viral replication. Nature (1999) 1.67
Influenza virus uncoating in infected cells and effect of rimantadine. J Gen Virol (1982) 1.43
The nucleic acid of Sendai virus and ribonucleic acid synthesis in cells infected by Sendai virus. J Gen Virol (1968) 1.36
Suppression of influenza virus replication in infected mice by protease inhibitors. J Gen Virol (1984) 1.17
Two forms of influenza virus nucleoprotein in infected cells and virions. Virology (1981) 1.15
Penetration of viral genetic material into host cell. Adv Virus Res (1982) 1.10
Uncoating of a rimantadine-resistant variant of influenza virus in the presence of rimantadine. J Gen Virol (1982) 1.02
Intracellular analysis of in vitro modified HIV Tat protein. J Biol Chem (1994) 0.97
Nucleoproteins of animal influenza viruses, in contrast to those of human strains, are not cleaved in infected cells. J Gen Virol (1984) 0.95
A modified plaque assay method for accurate analysis of infectivity of influenza viruses with uncleaved hemagglutinin. Arch Virol (1982) 0.94
Protein synthesis in Sendai virus-infected cells. J Gen Virol (1975) 0.93
Role of gangliosides in reception of influenza virus. Eur J Biochem (1982) 0.93
Myxovirus replication in chicken embryos can be suppressed by aprotinin due to the blockage of viral glycoprotein cleavage. J Gen Virol (1985) 0.92
Cytoplasmic and nuclear input virus RNPs in influenza virus-infected cells. J Gen Virol (1979) 0.91
Isolation of Sendai virus RNA from infected cells by the method of thermic fractionation. Biochim Biophys Acta (1966) 0.88
Infective substructures of Sendai virus from infected Ehrlich ascites tumor cells. J Virol (1968) 0.88
Induction of immune responses to SIV antigens by mucosally administered vaccines. AIDS Res Hum Retroviruses (1999) 0.87
Nucleotide and oligonucleotide derivatives as enzyme and nucleic acid targeted irreversible inhibitors. Biochemical aspects. Adv Enzyme Regul (1985) 0.86
Protective effect of protease inhibitors in influenza virus infected animals. Arch Virol (1982) 0.86
Highly immunogenic human immunodeficiency viruslike particles are produced by recombinant vaccinia virus-infected cells. AIDS Res Hum Retroviruses (1991) 0.85
Proteolytic activation of influenza WSN virus in cultured cells is performed by homologous plasma enzymes. J Gen Virol (1982) 0.85
Additive effect of histones and actinomycin D on the cellular RNA synthesis. Exp Cell Res (1966) 0.84
Deoxycholate-mediated cleavage of the protein of Sendai virus nucleocapsid derived from infected cells. Biochem Biophys Res Commun (1974) 0.83
Inhibition of HIV-1 replication by newly developed adamantane-containing polyanionic agents. Antiviral Res (1999) 0.82
Effect of protein synthesis inhibitors on the replication of virus-induced RNA in Sendai virus-infected cells. Acta Virol (1973) 0.81
Interaction of influenza virus with gangliosides and liposomes containing gangliosides. Eur J Biochem (1988) 0.80
Rimantadine hydrochloride blocks the second step of influenza virus uncoating. Arch Virol (1980) 0.80
The molecular organization of the influenza virus surface. Studies using photoreactive and fluorescent labeled phospholipid probes. Biochim Biophys Acta (1987) 0.78
Alphavirus replication in cultured cells and infected animals is inhibited by antiproteinase agents. Antiviral Res (1986) 0.78
Properties of intracytoplasmic A particles isolated from oncornavirus-producing human cells. J Virol (1974) 0.78
Intracellular virus-specific structures and RNAs in oncornavirus-producing human cells. J Virol (1974) 0.78
Fate of Sendai virus ribonucleoprotein in virus-infected cells. J Virol (1969) 0.77
Influenza virus assembly and its defects. Biosystems (1981) 0.77
Development of a rubella virus DNA vaccine. Vaccine (1999) 0.77
Abortive infection of influenza virus in Ehrlich ascites tumor cells. Unusual fragility of virus particles. Arch Virol (1978) 0.76
HIV-1 gag proteins in virions and in infected cell fractions. Biomed Sci (1991) 0.75
Template activity of parainfluenza virus ribonucleoprotein. Nature (1970) 0.75
Physicochemical properties of Sendai virus RNA. II. Effect of ionic strength on thermostability of RNA. Mol Biol (Mosk) (1977) 0.75
The properties of intracellular paramyxovirus ribonucleoprotein in a nonpermissive system. Arch Gesamte Virusforsch (1974) 0.75
[Formation of virus-like particles by HIV-1 Gag proteins, expressed by a recombinant vaccinia virus]. Mol Biol (Mosk) (1991) 0.75
Messenger activity of sendai virus ribonucleoprotein in a cell free protein-synthesizing system. Virology (1970) 0.75
Biophysical and biochemical properties of type B oncorna viruses isolated from continuous human cell cultures. Mol Biol (1974) 0.75
Formation of proviruses in acute infection in vitro and in vivo. Experientia (1977) 0.75
Enhancement of polysome formation and protein synthesis in Sendai virus-infected cells. J Gen Virol (1976) 0.75
Actinomycin D and histone action in myxovirus reproduction. Lancet (1966) 0.75
Action of influenza virus neuraminidase on gangliosides. Haemagglutinin inhibits viral neuraminidase. FEBS Lett (1985) 0.75
A comparison of influenza and parainfluenza and RNP properties. Arch Gesamte Virusforsch (1971) 0.75
Buoyant density of ribosomes of cytoplasmic extracts of mouse and chick cells. Mol Biol (1973) 0.75
Characteristics of Sendai virus RNA transcriptive complex formed in the cytoplasm of infected ascites cells. Acta Virol (1975) 0.75
Uncoiling and protein cleavage of paramyxovirus nucleocapsid after incubation with ribosomes in vitro. Biochim Biophys Acta (1973) 0.75
Matrix proteins of influenza A and B viruses possess common antigenic determinants. Lancet (1985) 0.75
Transcriptive functions of Sendai firus nucleocapsid in infected cells. Virology (1973) 0.75
Sedimentation and buoyant density characteristics of influenza virus ribonucleoprotein. Acta Virol (1973) 0.75
The intracellular site of RNA synthesis of Newcastle disease virus. Proc Soc Exp Biol Med (1966) 0.75
Influenza virus RNA-synthesizing complex in the nucleoplasm of infected cells. J Gen Virol (1975) 0.75
The participation of sendai virus ribonucleoprotein in virus-specific polysome formation. Virology (1969) 0.75
Presence of the p27 antigenicity and absence of the gp52 antigenicity and leukemia virus antigens in intracytoplasmic A particles (iAp) of mouse mammary tumour origin. Arch Geschwulstforsch (1976) 0.75
The properties of the Sendai virus ribonucleoproteins involved in genome transcription in infected cells. J Gen Virol (1974) 0.75
Action of histones on replication of myxoviruses. Fed Proc Transl Suppl (1967) 0.75
Replicative forms of Sendai virus RNA. Arch Gesamte Virusforsch (1970) 0.75
An amphipathic sequence in the cytoplasmic tail of HIV-1 Env alters cell tropism and modulates viral receptor specificity. Acta Virol (2015) 0.75
Properties of influenzavirus nucleocapsids in nonpermissive cells. Acta Virol (1979) 0.75
Influenza virus genetic sequences in the blood of children with congenital pathology of the CNS. Arch Virol (1989) 0.75
Association of viral ribonucleoprotein with polysomes. Experientia (1969) 0.75